Cargando…

Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators

The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Rohit, Bhushan, Sakshi, Kumar, Rakesh, Mannan, Rahul, Kaur, Pardeep, Singh, Amrit Pal, Singh, Bikram, Vig, Adarsh P., Sharma, Deepika, Arora, Saroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229223/
https://www.ncbi.nlm.nih.gov/pubmed/25390337
http://dx.doi.org/10.1371/journal.pone.0112614
_version_ 1782344103728513024
author Arora, Rohit
Bhushan, Sakshi
Kumar, Rakesh
Mannan, Rahul
Kaur, Pardeep
Singh, Amrit Pal
Singh, Bikram
Vig, Adarsh P.
Sharma, Deepika
Arora, Saroj
author_facet Arora, Rohit
Bhushan, Sakshi
Kumar, Rakesh
Mannan, Rahul
Kaur, Pardeep
Singh, Amrit Pal
Singh, Bikram
Vig, Adarsh P.
Sharma, Deepika
Arora, Saroj
author_sort Arora, Rohit
collection PubMed
description The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and γ-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin.
format Online
Article
Text
id pubmed-4229223
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42292232014-11-18 Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators Arora, Rohit Bhushan, Sakshi Kumar, Rakesh Mannan, Rahul Kaur, Pardeep Singh, Amrit Pal Singh, Bikram Vig, Adarsh P. Sharma, Deepika Arora, Saroj PLoS One Research Article The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and γ-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin. Public Library of Science 2014-11-12 /pmc/articles/PMC4229223/ /pubmed/25390337 http://dx.doi.org/10.1371/journal.pone.0112614 Text en © 2014 Arora et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Arora, Rohit
Bhushan, Sakshi
Kumar, Rakesh
Mannan, Rahul
Kaur, Pardeep
Singh, Amrit Pal
Singh, Bikram
Vig, Adarsh P.
Sharma, Deepika
Arora, Saroj
Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title_full Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title_fullStr Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title_full_unstemmed Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title_short Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
title_sort hepatic dysfunction induced by 7, 12-dimethylbenz(α)anthracene and its obviation with erucin using enzymatic and histological changes as indicators
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229223/
https://www.ncbi.nlm.nih.gov/pubmed/25390337
http://dx.doi.org/10.1371/journal.pone.0112614
work_keys_str_mv AT arorarohit hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT bhushansakshi hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT kumarrakesh hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT mannanrahul hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT kaurpardeep hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT singhamritpal hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT singhbikram hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT vigadarshp hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT sharmadeepika hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators
AT arorasaroj hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators